All Stories

  1. Development and screening of epoxy-spacer-phage cryogels for affinity chromatography: Enhancing the binding capacity

    Article • Journal of Separation Science, May 2017, Wiley

    Professor Hans Deckmyn

  2. Inhibitors of Platelet Adhesion to VWF and Collagen

    Article • January 2017, Springer Science + Business Media

    Professor Hans Deckmyn

  3. Assays for quality control of platelets for transfusion

    Article • ISBT Science Series, May 2013, Wiley

    Dr Hans Deckmyn, Professor Hans Deckmyn

  4. Blood platelet biochemistry

    Article • Thrombosis Research, March 2012, Elsevier

    Professor Hans Deckmyn

  5. New Insights into von Willebrand Disease and Platelet Function

    Article • Seminars in Thrombosis and Hemostasis, February 2012, Thieme Publishing Group

    Professor Riitta Lassila, Professor Hans Deckmyn

  6. Inhibitors of the Interactions Between Collagen and Its Receptors on Platelets

    Article • January 2012, Springer Science + Business Media

    Professor Hans Deckmyn

  7. Model systems of genetically modified platelets

    Article • Blood, December 2011, American Society of Hematology

    Dr. Tim Thijs, Professor Hans Deckmyn

  8. Platelet Functional Genomics

    Article • July 2011, Wiley

    Professor Hans Deckmyn

  9. Platelets at work in primary hemostasis

    Article • Blood Reviews, July 2011, Elsevier

    Professor Hans Deckmyn

  10. Platelet adhesion to collagen

    Article • Thrombosis Research, January 2011, Elsevier

    Dr. Tim Thijs, Professor Hans Deckmyn

  11. Roles of Src-like adaptor protein 2 (SLAP-2) in GPVI-mediated platelet activation

    Article • Thrombosis Research, October 2010, Elsevier

    Professor Hans Deckmyn

  12. Platelet physiology and antiplatelet agents

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2010, De Gruyter

    Dr. Tim Thijs, Professor Hans Deckmyn

  13. Humanization by Resurfacing

    Article • January 2010, Springer Science + Business Media

    Professor Hans Deckmyn

  14. Platelets and PEGylated lecithin liposomes: When stealth is allegedly picked up on the radar (and eaten)

    Article • Microvascular Research, June 2009, Elsevier

    Professor Hans Deckmyn

  15. von Willebrand factor to the rescue

    Article • Blood, March 2009, American Society of Hematology

    Professor Hans Deckmyn

  16. Von Willebrand Factor: Drug and Drug Target

    Article • Cardiovascular & Haematological Disorders - Drug Targets, March 2009, Bentham Science Publishers

    Professor Hans Deckmyn

  17. Deficiency of von Willebrand factor protects mice from ischemic stroke

    Article • Blood, January 2009, American Society of Hematology

    Professor Hans Deckmyn

  18. ADAMTS13 in Health and Disease

    Article • Acta Haematologica, January 2009, Karger Publishers

    Professor Hans Deckmyn

  19. Laboratory Diagnosis and Molecular Classification of von Willebrand Disease

    Article • Acta Haematologica, January 2009, Karger Publishers

    Professor Hans Deckmyn

  20. Chromato-panning: an efficient new mode of identifying suitable ligands from phage display libraries

    Article • BMC Biotechnology, January 2009, Springer Science + Business Media

    Professor Hans Deckmyn

  21. Multiple ways to switch platelet integrins on and off

    Article • Journal of Thrombosis and Haemostasis, August 2008, Wiley

    Professor Hans Deckmyn

  22. Antiplatelet drugs

    Article • British Journal of Haematology, May 2008, Wiley

    Professor Hans Deckmyn

  23. Inherited traits affecting platelet function

    Article • Blood Reviews, May 2008, Elsevier

    Professor Hans Deckmyn

  24. Inhibition of Platelet Glycoprotein Ib and Its Antithrombotic Potential

    Article • Current Pharmaceutical Design, September 2007, Bentham Science Publishers

    Professor Hans Deckmyn

  25. False positive results in chimeraplasty for von Willebrand Disease

    Article • Thrombosis Research, January 2007, Elsevier

    Professor Hans Deckmyn

  26. When collagen meets VWF

    Article • Blood, December 2006, American Society of Hematology

    Professor Hans Deckmyn

  27. Role of glycoprotein Ib? in phagocytosis of platelets by macrophages

    Article • Transfusion, December 2006, Wiley

    Professor Hans Deckmyn

  28. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIbα

    Article • Thrombosis and Haemostasis, November 2006, Schattauer GmbH

    Professor Hans Deckmyn

  29. Immobilised peptide displaying phages as affinity ligands

    Article • Journal of Chromatography A, January 2006, Elsevier

    Professor Hans Deckmyn

  30. Shielding of the A1 Domain by the D′D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V

    Article • Journal of Biological Chemistry, December 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Hans Deckmyn

  31. Crystal Structure and Paratope Determination of 82D6A3, an Antithrombotic Antibody Directed Against the von Willebrand factor A3-Domain

    Article • December 2005, Protein Data Bank, Rutgers University

    Professor Hans Deckmyn

  32. How does agkicetin-C bind on platelet glycoprotein Ibα and achieve its platelet effects?

    Article • Toxicon, April 2005, Elsevier

    Professor MAIKUN TENG, Professor Hans Deckmyn

  33. Identification of Residues within Human Glycoprotein VI Involved in the Binding to Collagen

    Article • Journal of Biological Chemistry, October 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Hans Deckmyn

  34. The Hemostatic System

    Article • Current Medicinal Chemistry, September 2004, Bentham Science Publishers

    Professor Hans Deckmyn

  35. New Approaches for Antithrombotic Antiplatelet Therapies

    Article • Current Medicinal Chemistry, September 2004, Bentham Science Publishers

    Professor Hans Deckmyn

  36. Platelet antigens and their function

    Article • Vox Sanguinis, July 2004, Wiley

    Professor Hans Deckmyn

  37. The GPIbα–thrombin interaction: far from crystal clear

    Article • Trends in Molecular Medicine, January 2004, Elsevier

    Professor Hans Deckmyn

  38. New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets

    Article • Experimental Hematology, January 2004, Elsevier

    Professor Hans Deckmyn

  39. Inhibition of Platelet Adhesion to Collagen as a New Target for Antithrombotic Drugs

    Article • Current Drug Targets - Cardiovascular & Hematological Disorders, June 2003, Bentham Science Publishers

    Professor Hans Deckmyn

  40. Integrin αIIbβ3 and shear-dependent action of glycoprotein ibα stimulate platelet-dependent thrombin formation in stirred plasma

    Article • Journal of Laboratory and Clinical Medicine, May 2003, Elsevier

    Professor Hans Deckmyn

  41. The role of VWF-collagen interaction in acute platelet thrombus formation

    Article • Drugs of the Future, January 2003, Prous Science

    Professor Hans Deckmyn

  42. A Reliable von Willebrand Factor: Ristocetin Cofactor Enzyme-Linked Immunosorbent Assay to Differentiate between Type 1 and Type 2 von Willebrand Disease

    Article • Seminars in Thrombosis and Hemostasis, January 2002, Thieme Publishing Group

    Professor Hans Deckmyn

  43. 5 Inhibitory and activating human antiplatelet antibodies

    Article • Baillière s Clinical Haematology, June 1998, Elsevier

    Professor Hans Deckmyn

  44. The effect of plasmin on platelet function

    Article • Platelets, January 1996, Taylor & Francis

    Professor Hans Deckmyn

  45. Platelet actuation

    Article • Blood Reviews, September 1995, Elsevier

    Professor Hans Deckmyn

  46. Functional Effects of Human Antiplatelet Antibodies

    Article • Seminars in Thrombosis and Hemostasis, January 1995, Thieme Publishing Group

    Professor Hans Deckmyn

  47. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation

    Article • Circulation, November 1994, Wolters Kluwer Health

    Professor Hans Deckmyn

  48. Dose-Dependent Inhibition of Acute Arterial Thrombosis by Monoclonal Antibody (16N7C2) in a Baboon Model

    Article • January 1994, Springer Science + Business Media

    Professor Hans Deckmyn

  49. Dual Regulation of Phospolipase C Activity by G Proteins

    Article • Physiology, April 1993, American Physiological Society

    Professor Hans Deckmyn

  50. Thromboxane synthase inhibitors and receptor antagonists

    Article • Cardiovascular Drugs and Therapy, February 1992, Springer Science + Business Media

    Professor Hans Deckmyn

  51. Absence of plasminogen activator inhibitor type I (PAI-1) in a human platelet-derived λgtII expression library

    Article • Thrombosis Research, January 1992, Elsevier

    Professor Hans Deckmyn

  52. THROMBOSIS IN INJURED SMALL VESSELS

    Article • Plastic & Reconstructive Surgery, July 1991, Wolters Kluwer Health

    Professor Hans Deckmyn

  53. Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders

    Article • Trends in Pharmacological Sciences, January 1991, Elsevier

    Professor Hans Deckmyn

  54. Phosphatidylinositol Phospholipase C

    Article • January 1990, Elsevier

    Professor Hans Deckmyn

  55. The platelet insulin receptor: Detection, partial characterization, and search for a function

    Article • Biochemical and Biophysical Research Communications, December 1988, Elsevier

    Professor Hans Deckmyn

  56. The Metabolism of Inositol Phosphates

    Article • January 1988, Springer Science + Business Media

    Professor Hans Deckmyn

  57. The metabolism of phosphoinositide-derived messenger molecules

    Article • Science, December 1986, American Association for the Advancement of Science

    Professor Hans Deckmyn

  58. Continuous inhibition of the platelet S2-serotonergic receptors during the long term administration of ketanserin

    Article • Thrombosis Research, June 1986, Elsevier

    Professor Hans Deckmyn

  59. Immunomodulatory effects of treatment with naproxen in patients with rheumatic disease

    Article • Arthritis & Rheumatism, March 1986, Wiley

    Professor Hans Deckmyn

  60. Intravenous Ionic Contrast Media Cause Local Prostacyclin Release in Man

    Article • Investigative Radiology, November 1985, Wolters Kluwer Health

    Professor Hans Deckmyn

  61. THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS

    Article • The Lancet, May 1985, Elsevier

    Professor Hans Deckmyn

  62. COMBINING ANTIPLATELET AGENTS: POTENTIATION BETWEEN ASPIRIN AND DIPYRIDAMOLE

    Article • The Lancet, April 1985, Elsevier

    Professor Hans Deckmyn

  63. Effects of thromboxane A2 on lymphocyte proliferation

    Article • Cellular Immunology, February 1985, Elsevier

    Professor Hans Deckmyn

  64. Lack of synergism between dazoxiben and dipyridamole following administration to man

    Article • Thrombosis Research, January 1985, Elsevier

    Professor Hans Deckmyn

  65. Manipulation of Pro- and Antiaggregating Prostaglandins: New Antithrombotic Strategies

    Article • January 1985, Springer Science + Business Media

    Professor Hans Deckmyn

  66. Platelet Hypersensitivity to Serotonin After Prolonged Ketanserin Intake?

    Article • Journal of Cardiovascular Pharmacology, January 1985, Wolters Kluwer Health

    Professor Hans Deckmyn

  67. Prostacyclin in pregnancy

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, December 1984, Elsevier

    Professor Hans Deckmyn

  68. PROLONGING PROSTACYCLIN PRODUCTION BY NAFAZATROM OR DIPYRIDAMOLE

    Article • The Lancet, August 1984, Elsevier

    Professor Hans Deckmyn

  69. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2

    Article • Biochemical Pharmacology, July 1984, Elsevier

    Professor Hans Deckmyn

  70. BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN

    Article • The Lancet, May 1984, Elsevier

    Professor Hans Deckmyn

  71. Low prostacyclin synthetase activity of fetal rat aorta. Progressive increase after birth.

    Article • Life Sciences, October 1983, Elsevier

    Professor Hans Deckmyn

  72. Prostacyclin production by whole blood from children : Impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure

    Article • Thrombosis Research, April 1983, Elsevier

    Professor Hans Deckmyn

  73. Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observations.

    Article • British Journal of Clinical Pharmacology, February 1983, Wiley

    Professor Hans Deckmyn

  74. The effect of sulphinpyrazone on whole blood thromboxane and prostacyclin generation in man

    Article • Thrombosis Research, October 1982, Elsevier

    Professor Hans Deckmyn

  75. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2

    Article • Thrombosis Research, June 1982, Elsevier

    Professor Hans Deckmyn